#healthcare-innovation

#healthcare-innovation

Here's the uncomfortable truth: Most founders are still chasing yesterday's markets. They're building tools for productivity, or consumer apps that feel safe and familiar. Meanwhile, a new generation of companies is tackling the most universal customer need on earth - more years of energy, clarity and performance. This isn't wellness 2.0. This is the redefinition of healthcare, insurance, consumer products and even food. By 2030, the longevity economy will be worth an estimated $27 trillion globally. For business leaders, this represents a once-in-a-generation category: It touches everyone, enables recurring revenues and rewards those who build early.

Success isn't about one big moment. It's about small, reliable actions over time.

Peter Diamandis envisions a future where death may become optional, arguing that advancements in technology and understanding of biological systems could allow for extended life. He noted that it's a challenge, likening the human body to a complex machine with forty trillion cells, each executing billions of reactions. He expressed optimism about the role of AI and robotics in unraveling these mysteries, stating, 'We are linear thinkers in an exponential world,' emphasizing the potential acceleration of research through technological innovations.

The PREVENT equations were developed in 2023 to enhance the accuracy of cardiovascular disease risk predictions in a diverse patient cohort, improving preventive care efforts.

The integration of generative artificial intelligence and machine learning into robotic surgical systems like Da Vinci is advancing towards fully autonomous surgical robots capable of performing procedures independently.

Wearables are described as devices that range from smartwatches measuring step counts to sophisticated rings analyzing sleep patterns, cardio-respiratory fitness, and stress levels.

The North London NHS Foundation Trust's Digital, Data, and AI Academy was honored with the Digital Literacy, Education, and Upskilling Award at the HSJ Digital Awards 2025 for its effective IT training program.

With this strategic injection, UNIIQ is giving both the young companies and the regional innovation ecosystem a boost.

"It may be one of the first dementias to have a definitive treatment, a cure if you like, a really transformative treatment that allows people to live much longer and much more normal lives..."

They want independence, Petty said, but once they require help with managing medications or other needs, they are often transitioned into an assisted living environment.

Unlike a linear taper that reduces medication by the same amount, a hyperbolic taper gradually slows the rate of reduction, resulting in very small and spaced-out doses.

With increasing patient needs and healthcare costs, myLaurel is pioneering home-based care models, significantly cutting hospital admissions and improving patient outcomes.

The Oregon Health and Science University developed a new cancer treatment using ultrasound and engineered particles that break down tumors without major side effects.

In October last year, the Department for Health and Social Care said the SPR would help create a 'more modern NHS.' It will put patients in control of their own medical history.

"Clinicians treating very obese children in Sweden found that liraglutide injections combined with lifestyle changes resulted in a significant weight loss success rate, avoiding mealtime conflicts."

"Chrome's V8 team has introduced an innovative feature that significantly enhances JavaScript's performance, making it ten times faster and revolutionizing web applications and user experience."

The innovative dengue fever test kit by Crux Product Design integrates microneedle technology into a simple patch, enhancing testing access and user-friendliness in resource-limited areas.

Brightline's Brooklyn clinic launch is the first of several planned clinics in New York.

The dual challenge of rising healthcare expectations and labor shortages necessitates the adoption of innovative technologies for improving efficiency and patient care.

Phosphoenix has a unique neurotech solution to (partially) restore the vision of blind people. With this financing from Innovatiefonds Noord-Holland, we hope to advance this groundbreaking technology.

Eli Lilly is on track to become the first healthcare company to reach a $1 trillion market cap, driven by its dominance in the GLP-1 market.